Clinical trial · Interventional
Developing an mHealth Application to Improve Cancer Chemotherapy Symptom Management
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This research project addresses critical gaps in cancer symptom management through the creation of a mobile chemotherapy symptom management application. This application will assess for the presence and severity of common chemotherapy side-effects and provide personally tailored symptom-related video and narratives to enhance self-management of cancer and treatment-related symptoms. This study will examine patient acceptance and use of this mHealth application (called MyChemoCare) in a prospective trial of cancer patients (n=60) who are receiving chemotherapy for colorectal cancer at the University of Michigan Comprehensive Cancer Center.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colon Cancer | Malignant Colon Neoplasm | CURATED_EXACT | 0.92 |
| Rectal Cancer | Malignant Rectal Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| MyChemoCare iPad application | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- MyChemoCare
- description
- Participants will receive access to the the MyChemoCare iPad application, which allows them to track cancer and chemotherapy related symptoms daily, and suggests strategies that may help the participant deal with these symptoms. While using the application, high symptom severity scores will be reported to the participant's medical team, who may intervene to help relieve the symptom. Participants will also be contacted if they have not checked in for 48 hours to make sure they are coping well with their chemotherapy regimen.
- interventionNames
- Device: MyChemoCare iPad application
Primary outcomes (2)
- measure
- Patient Retention and Engagement With the MyChemoCare Application
- timeFrame
- 8 weeks post-enrollment
- description
- Patient retention is defined as the number of patients who completed the 8-week study through the final evaluation. Engagement with the MyChemoCare application was measured as number of patients who checked in at least once per week of the study.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Diagnosed with colon or rectal cancer * Expected to live at least 6 months * Initiating chemotherapy for the first time in their treatment history * Physically and mentally able to participate * Able to read English * Willing and able to sign informed consent Exclusion Criteria: * A treatment plan that does not include cytotoxic chemotherapy for colon or rectal cancer * A medical history that includes cancer with the exception of in situ cancers of the cervix and basal cell cancers of the skin * A current diagnosis that includes multiple cancers (this does not exclude metastatic disease) * Received prior cytotoxic chemotherapy for any reason * A diagnosed psychiatric disorder
References
Publications (0)
Data not yet available